ClinicalTrials.Veeva

Menu

Subacromial Space in Chronic Stroke Patients

A

Ankara University

Status

Completed

Conditions

Stroke

Study type

Observational

Funder types

Other

Identifiers

NCT07139665
bbff9d0fc1ae4783

Details and patient eligibility

About

This study aims to examine the subacromial space, shoulder pain, and shoulder disability in chronic stroke patients. A total of 60 chronic stroke patients aged 40-65 with similar demographic characteristics are planned to be included in this study. Participants will be selected voluntarily from among chronic stroke patients presenting for routine examination and follow-up at the Neurology Outpatient Clinic of Başkent University Hospital and meeting the appropriate inclusion criteria. Detailed demographic information (age, gender, stroke duration, affected side, etc.) will be recorded for all individuals included in the study.

Full description

During the clinical assessment process, the subacromial space distance between the hemiplegic (affected) and healthy sides of the participants will be compared, and shoulder pain levels and shoulder disability levels will be examined. In this context, the subacromial space distance in the shoulder joint will be measured objectively using ultrasonography according to standard protocols. The severity of shoulder pain experienced by participants will be assessed subjectively using a Visual Analog Scale (VAS). Shoulder-related functional limitations and disability levels will be determined using a validated questionnaire, such as the Shoulder Pain and Disability Index (SPADI). Based on the data obtained, the relationships between subacromial distance, shoulder pain, and shoulder disability levels will be statistically analyzed. To ensure the statistical power of the study, a sample size target of 85% will be calculated, and additional individuals will be included if necessary to reach the specified sample size.

Enrollment

51 patients

Sex

All

Ages

40 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being between the ages of 40 and 65.
  • Scoring 21 or higher on the Montreal Cognitive Assessment Scale (MoCA).
  • Being diagnosed with an ischemic or hemorrhagic stroke by a neurologist and having experienced the stroke for at least 6 months (chronic stroke).
  • Scoring between 0 and 3 on the Modified Rankin Score.
  • Volunteering to participate in the study

Exclusion criteria

  • Difficulty with verbal communication (severe aphasia, cognitive impairment, etc.) that would prevent participation in the study and understanding the test instructions.
  • Severe visual or hearing impairment that would affect test administration or safety.
  • Having another neurological condition (e.g., Parkinson's disease, Multiple Sclerosis, severe peripheral neuropathy) other than stroke that could affect shoulder function or pain.
  • Having a history of shoulder surgery before or after stroke, known rotator cuff tear, shoulder dislocation, severe degenerative joint disease (osteoarthritis), or inflammatory rheumatic disease (e.g., rheumatoid arthritis).
  • Congestive heart failure, uncontrolled hypertension, or other serious cardiopulmonary disease that would preclude physical assessment or have exercise/positioning limitations.

Trial design

51 participants in 1 patient group

Chronic Stroke Patiens

Trial contacts and locations

1

Loading...

Central trial contact

Büşra Seçkinoğulları Korkusuz, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems